PG Versus TG for Advanced PGC

Not Applicable

Active, not recruiting

• Conditions: Gastric Adenocarcinoma; Gastrectomy

• Registration Number: NCT06614439
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

We conducted a retrospective study on patients with pathological stage II-III PGC who underwent PG or TG from 2013 to 2023. Propensity score-matching was applied to adjust for tumor size and stage between the PG and TG groups at a 1:1 ratio. We evaluated the procedural safety, oncological, and functional outcomes.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-09
• Study Start: 2024-09-04
• Study First Submitted: 2024-09-23
• Study First Submitted QC: 2024-09-25
• Last Update Submitted: 2024-09-25
• Study First Posted: 2024-09-26
• Last Update Posted: 2024-09-26
• Primary Completion: 2024-09-30
• Study Completion: 2024-10-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

• Proximal gastric adenocarcinoma after total or proximal gastrectomy.

Exclusion Criteria

• Non-curative resections
• Non-adenocarcinoma histology
• Distally located tumors or middle/proximally located tumors for which distal margin could not be secured by PG
• Remnant gastric cancer
• Clinically T1N0 tumors smaller than 3 cm for which PG was clearly indicated

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
five-year overall survival	5 years

Trial Locations

Locations (1)

National Taiwan University Hospital Hsin-Chu Branch; 🇨🇳 Hsin-Chu County, Taiwan

National Taiwan University Hospital Hsin-Chu Branch

🇨🇳Hsin-Chu County, Taiwan